Skin Permeability of Water-Soluble Drugs

Chemical and Pharmaceutical Bulletin

Volumn 37, Issue 5, 1989, Pages 1404-1406

  Okumura, Mutsuo ^a,b   Ogawa, Keizaburo ^a   Sugibayashi, Kenji ^b   Morimoto, Yasunori ^b  

^a Omiya Research Laboratory Co Ltd ^*  (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

deuterium oxide; excised hairless rat skin; indomethacin; skin permeation; water soluble drug

Indexed keywords

CROMOGLYCATE DISODIUM; DEUTERIUM OXIDE; DICLOFENAC; DILTIAZEM; DOPAMINE; INDOMETACIN; ISOPRENALINE; PAPAVERINE;

ANIMAL CELL; BIOLOGICAL MODEL; DRUG SOLUBILITY; MOLECULAR WEIGHT; NONHUMAN; PARTITION COEFFICIENT; RAT; SKIN PERMEABILITY;

ANIMAL; CHEMISTRY, PHYSICAL; IN VITRO; MALE; MICE; MICE, INBRED STRAINS; SKIN ABSORPTION; SOLUBILITY;

EID: 0024375502     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.37.1404     Document Type: Article

References (9)

1. K. Sugibayashi, M. Nemoto, and Y. Morimoto, Chem. Pharm. Bull., 36, 1519 (1988); A. J. Georgopoulos, A. Markis and H. Georgiadis, Eur. J. Clin. Pharm., 22, 481 (1982).
2. B. W. Barry, “Dermatological Formulations,” Marcel Dekker, New York and Basle, 1983, p. 110.
3. R. B. Stoughton and W. O. McClure, Drug Dev. Ind. Pharm., 9, 725 (1983);
4. K. Sugibayashi, K. Hosoya, Y. Morimoto and W. I. Higuchi, J. Pharm. Pharmacol., 37, 578 (1986)
5. Y. Morimoto, K. Sugibayashi, K. Hosoya and W. I. Higuchi, Int. J. Pharmaceut., 32, 31 (1986).
6. R. R. Burnette and D. Marrero, J. Pharm. Sci., 75, 738 (1986); L. P. Gangarosa, N. Park, C. A. Wiggins and J. M. Hill, J. Pharm. Exp. Ther., 212, 377 (1980).
7. Y. Moriyama, K. Furuya, A. Kondo, T. Takeuti and M. Shimizu, Yakkyoku, 28, 473 (1977).
8. K. Sato, K. Sugibayashi and Y. Morimoto, Int. J. Pharmaceut., 43, 31 (1988).
9. G. L. Flynn, S. H. Yalkowsky and T. J. Roseman, J. Pharm. Sci., 63, 479 (1974).